The short version
- Why people research itSoft-tissue and gut repair, reduced inflammation, angiogenesis and faster recovery from injury.
- What the evidence isNo randomized human trials — a research compound with no commercial route to funding one, so the correlative and theoretical tiers are the evidence base rather than a consolation prize.
- What to watchFever or pain that lingers while inflammation looks quiet.
How KPV works
Anti-inflammatory tripeptide from α-MSH — calms NF-κB signaling systemically and in the gut.
KPV is Lys-Pro-Val, residues 11–13 of alpha-melanocyte-stimulating hormone — the last three amino acids of the hormone, and nothing else. 342.4 Da as the free acid, formula C16H30N4O4. The lysine side chain is the only ionizable group besides the termini and there is no acidic residue at all, so the computed isoelectric point is 9.7 and the net charge is about +0.9 at blood pH.
The identity question no label answers. In the parent hormone the valine is amidated — alpha-MSH ends in Val-NH2. Research KPV is usually sold as the free acid.
- Injectable
- Oral
On the goal map: Gut lining & mucosal repair (Heal an injury)
Research on KPV4 evidence notes: clinical, correlative, mechanism
Each note is labeled by the kind of evidence it stands on. Unproven is not ineffective: a missing trial means nobody has run it yet. How the evidence tiers work
Human clinical evidence
No randomized human trials — a research compound with no commercial route to funding one, so the correlative and theoretical tiers are the evidence base rather than a consolation prize.
No completed human trial
Correlative data
Alpha-MSH, the parent hormone KPV is the C-terminal fragment of, has been studied in humans for inflammatory conditions. KPV itself is used orally for gut inflammation and topically for skin, with a reported profile of being quietly effective and almost entirely without side effects — which is consistent with a fragment that lacks the parent's receptor activity.
How the mechanism reads
The tripeptide carries alpha-MSH's anti-inflammatory action without its melanocortin receptor binding — so it is predicted to calm inflammation without the pigmentation, flushing or erectile effects the full hormone causes. That separation is the entire reason to use the fragment.
MechanisticAnd the mechanism (NF-κB inhibition in gut epithelium) is why oral delivery makes sense here when it would not for most peptides.
Experimental, animal or cell
Sources
- Dalmasso G, Charrier-Hisamuddin L, Nguyen HT, Yan Y, Sitaraman S, Merlin D. PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation. Gastroenterology 2008 · PMID 18061177
- Kannengiesser K, et al. Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel disease. Inflammatory Bowel Diseases 2008 · PMID 18092346
- Getting SJ, et al. Dissection of the anti-inflammatory effect of the core and C-terminal (KPV) alpha-melanocyte-stimulating hormone peptides. Journal of Pharmacology and Experimental Therapeutics 2003 · PMID 12750433
- Charnley M, et al. Anti-microbial action of melanocortin peptides and identification of a novel X-Pro-D/L-Val sequence in Gram-positive and Gram-negative bacteria. Peptides 2008 · PMID 18355945
- Brzoska T, et al. Terminal signal: anti-inflammatory effects of alpha-melanocyte-stimulating hormone related peptides beyond the pharmacophore. Advances in Experimental Medicine and Biology 2010 · PMID 21222263
- Xiao B, et al. Orally Targeted Delivery of Tripeptide KPV via Hyaluronic Acid-Functionalized Nanoparticles Efficiently Alleviates Ulcerative Colitis. Molecular Therapy 2017 · PMID 28143741
KPV safety basicsWho should avoid it, what to expect, what to watch
Avoid if
- An untreated infection, because dampening NF-kB signaling can blunt the warning signs.
- Persistent blood in stool or bowel change that has not been diagnosed.
- Allergy to melanocortin peptides.
- Pregnancy or breastfeeding, where melanocortin peptides are unstudied.
What’s expected
- Calmer inflammatory signaling in the gut after uptake through PepT1.
- It is not a growth factor and not pro-angiogenic.
- Mild stomach upset as the peptide is absorbed via PepT1.
Watch for
- Fever or pain that lingers while inflammation looks quiet.
- Blood in the stool that does not go away.
- Hives or flushing.
Labs that tell you it’s working
- hs-CRP: a fall shows the anti-inflammatory arm is landing.
- ESR: slower inflammation read in chronic gut disease.
- Complete Blood Count: anemia and white cells point to gut inflammation severity.
Lys-Pro-Val C-terminal tripeptide of alpha-MSH: reduces NF-kB signaling and gut inflammation; it is not an angiogenic repair peptide. PMID 18061177 PMID 18092346 PMID 12750433
Bloodwork to runHow you would know it is working: 8 tests in one order, code CAMERON
A panel picked from how it works and what it can move: the tests, and why each is on it.
Code CAMERON applies automatically. The before and after schedule and how to read the results are in the Skool lesson.
KPV FAQ4 common questions
- Is KPV approved for human use?
- No. KPV is a research compound. No completed randomized human trial has given it yet.
- What is KPV researched for?
- Soft-tissue and gut repair, reduced inflammation, angiogenesis and faster recovery from injury.
- Which labs show whether it's doing anything?
- hs-CRP; ESR; Complete Blood Count: a baseline before you start and a recheck after. The panel on this page orders them in one cart.
- Where's the full protocol?
- In the Skool lesson for KPV: the protocol, dose and schedule, timing, what to stack, the cycle answer, the bloodwork plan and the cheat sheet. Protocol & dosing live there, not on the public site.





